We are live on ! Find out more
MTNB icon

Matinas BioPharma
MTNB

61 hedge funds and large institutions have $34.8M invested in Matinas BioPharma in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 8

0.02% less ownership

Funds ownership: 0.48% → 0.46% (-0.02%)

5% less capital invested

Capital invested by funds: $36.7M → $34.8M (-$1.91M)

6% less funds holding

Funds holding: 65 → 61 (-4)

36% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 11

Holders
61
Holders Change
-4
Holders Change %
-6.15%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
13
Reduced
8
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
+$479K
2
SIG
Sargent Investment Group
Maryland
+$364K
3
Two Sigma Investments
Two Sigma Investments
New York
+$148K
4
WG
Winton Group
United Kingdom
+$109K
5
BCM
Bridgeway Capital Management
Texas
+$104K

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$1.62M
2
Millennium Management
Millennium Management
New York
-$279K
3
Renaissance Technologies
Renaissance Technologies
New York
-$206K
4
Jane Street
Jane Street
New York
-$199K
5
Wells Fargo
Wells Fargo
California
-$153K
Name Holding Trade Value Shares
Change 		Change in
Stake
Franklin Resources
51
Franklin Resources
California
$8K – – –
LA
52
Legacy Advisors
Pennsylvania
$8K +$7.95K +200 New
Ameriprise
53
Ameriprise
Minnesota
$8K +$8.71K +219 New
JC
54
JBF Capital
Colorado
$5K +$5.37K +135 New
HFM
55
Hartford Financial Management
Connecticut
$2K – – –
SPIA
56
Steward Partners Investment Advisory
New York
$2K – – –
CAL
57
Capital Analysts LLC
Pennsylvania
$1K – – –
Millennium Management
58
Millennium Management
New York
$37 -$279K -7,023 -88%
BNP Paribas Financial Markets
59
BNP Paribas Financial Markets
France
$19 – – –
BBA
60
Baker Bros. Advisors
New York
– -$1.62M -41,928 Closed
Renaissance Technologies
61
Renaissance Technologies
New York
– -$206K -5,340 Closed
Jane Street
62
Jane Street
New York
– -$199K -5,158 Closed
CAG
63
Crestwood Advisors Group
Massachusetts
– -$110K -2,850 Closed
Hudson Bay Capital Management
64
Hudson Bay Capital Management
Connecticut
– -$57K -1,500 Closed
Russell Investments Group
65
Russell Investments Group
United Kingdom
– -$40K -1,038 Closed
ECM
66
ExodusPoint Capital Management
New York
– -$16K -422 Closed
GCP
67
GSA Capital Partners
United Kingdom
– -$15K -384 Closed
ARTA
68
A.R.T. Advisors
New York
– -$10K -267 Closed
SPC
69
Sigma Planning Corp
Michigan
– -$10K -252 Closed
PA
70
Planning Alternatives
Michigan
– -$8K -200 Closed
1 2
3

MTNB Hedge Fund Activity: Q3 2020 in Review

61 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Matinas BioPharma (MTNB) for Q3 2020, worth a combined $34.8M — down 5.2% from $36.7M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of MTNB and 7 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 13 added.

The largest buyer was Two Sigma Advisers, adding an estimated $479K. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $1.62M sold.

  • 61 institutional investors held Matinas BioPharma (MTNB) as of Q3 2020, down from 65 in Q2 2020.
  • Funds reported $34.8M of Matinas BioPharma stock for Q3 2020, down 5.2% quarter-over-quarter.
  • 7 funds opened new Matinas BioPharma positions in Q3 2020 and 11 closed out, a net change of -4 holders.
  • The largest Matinas BioPharma buyer in Q3 2020 was Two Sigma Advisers, an estimated $479K added.
  • The largest Matinas BioPharma seller in Q3 2020 was Baker Bros. Advisors, an estimated $1.62M sold.

Based on aggregated 13F filings for Q3 2020.